Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Scaling Care is a venture capital fund established to invest in early-stage health and bio infrastructure. Founded in the United States, the firm has a total capital of $10 million, which it allocates to companies that operate within established regulatory frameworks. The fund emphasizes investments in businesses that can navigate known FDA pathways, ensuring that their products meet necessary compliance standards.
Since its inception, Scaling Care has focused on supporting startups that demonstrate potential through clinical trials and have established reimbursement pathways. The firm aims to provide non-dilutive capital, allowing founders to fund trials and pilots without sacrificing equity. This approach positions Scaling Care as a valuable partner for entrepreneurs in the health and biotech sectors.
Scaling Care concentrates its investments on health and bio infrastructure, specifically targeting companies that have established FDA pathways for their products. This includes those with 510(k) or De Novo classifications for Class I and II medical devices. The fund seeks to support startups that can demonstrate value through clinical trials and have established reimbursement pathways, which are critical for market entry and sustainability.
The investment strategy of Scaling Care emphasizes the importance of leveraging data to strengthen clinical claims. By focusing on non-dilutive capital, the firm enables founders to finance trials and pilots without giving up equity, thus aligning the interests of both the investors and the entrepreneurs.
Lauren M Taylor - General Partner. Lauren has extensive experience in venture capital and healthcare investments.
Jennifer Duggan - Former Director of Global Clinical Studies at Abbott. Jennifer brings a wealth of knowledge in clinical research and regulatory affairs.
Katie Baca-Motes - Founder of Scripps Research Digital Trial Center. Katie specializes in digital health and clinical trial innovation.
Betiel Hadgu Haile - Evidence & Operations at Roche and Clinical Research Instructor at UC Berkeley. Betiel has expertise in clinical research methodologies.
Julia Rozman - Strategic Advisory Scientist at BARDA DRIVe. Julia focuses on strategic initiatives in health innovation.
Christian Laurence-Diaz - Former Senior Analyst at HHS, specializing in Medicare and Medicaid. Christian has a strong background in health policy.
Elyse Heob - Co-Founder of ClearMask and former CDC and Booz Allen employee. Elyse has experience in public health and healthcare innovation.
Adam Casson - Serial Founder in Health/Bio, with prior roles at GE Healthcare and Edison AI. Adam has a strong entrepreneurial background.
Arvita Tripati - GTM Strategy at Redesign Health. Arvita specializes in go-to-market strategies for health startups.
Eve Blossom - Serial Founder in Health & FinTech and Investor, Aspen Fellow. Eve has a diverse background in health and financial technology.
Benjamin Bimanywaruhanga - Pharmacist at CVS Health and Founder, Angel, LP. Benjamin has expertise in pharmacy and investment.
To pitch Scaling Care, founders should send their decks to laurenmtaylor@scalingcare.fund. It is important to include information about the regulatory pathways for the product, clinical trial data, and reimbursement strategies. Clear and concise presentations that outline the startup's value proposition and market potential are recommended.
What are Scaling Care's investment criteria?
Scaling Care invests in early-stage health and bio infrastructure companies that have established FDA pathways for their products. They focus on startups that can demonstrate value through clinical trials and have established reimbursement pathways.
How can I pitch to Scaling Care?
Interested parties can send their investment decks directly to laurenmtaylor@scalingcare.fund. It is advisable to clearly outline the regulatory pathways and clinical data supporting your product.
What makes Scaling Care different from other investors?
Scaling Care emphasizes non-dilutive capital, allowing founders to fund trials and pilots without giving up equity. This approach is particularly beneficial for startups in the health and biotech sectors, where funding for trials can be substantial.
What stages does Scaling Care invest in?
The firm invests at the Pre-seed, Seed, and Series A stages, focusing on early-stage companies that are navigating the complexities of health and bio infrastructure.
What geographic areas does Scaling Care focus on?
Scaling Care primarily invests in companies based in the United States, aligning with its focus on health and bio infrastructure within established regulatory frameworks.
What type of support does Scaling Care provide post-investment?
While specific details on post-investment support are not disclosed, the firm’s focus on non-dilutive capital suggests a commitment to helping founders navigate trials and regulatory processes effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.